FDA Gives Approval For Prialt; Elan Prepares January Launch Dec. 30, 2004 Elan Corp. plc will be ringing in the new year with another product approval, this time for the snail venom pain product, Prialt. (BioWorld Today)Read More
ImmunoGen, Centocor Partner In Potential $43.5M TAP Deal Dec. 29, 2004 ImmunoGen Inc. licensed certain rights to its Tumor-Activated Prodrug (TAP) technology to Centocor Inc. in a deal worth up to $43.5 million, plus royalties. (BioWorld Today)Read More
RSS